Establishment of reference intervals of clinical chemistry analytes for the adult population in Saudi Arabia: A study conducted as a part of the IFCC global study on reference values

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 5, 2016, Pages 843-855

  Borai, Anwar ^a   Ichihara, Kiyoshi ^b   Al Masaud, Abdulaziz ^c   Tamimi, Waleed ^c   Bahijri, Suhad ^d   Armbuster, David ^e   Bawazeer, Ali ^a   Nawajha, Mustafa ^a   Otaibi, Nawaf ^c   Khalil, Haitham ^a   Kawano, Reo ^b   Kaddam, Ibrahim ^a   Abdelaal, Mohamed ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e ABBOTT LABORATORIES   (United States)

Author keywords

Architect; C RIDL; IFCC; multicenter study; reference interval; Saudi population

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL CHEMISTRY; CONTROLLED STUDY; EXERCISE; FEMALE; GENDER; HUMAN; LANGUAGE; LIFESTYLE; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; RELIGION; SAMPLE SIZE; SAUDI; SAUDI ARABIA; SMOKING; ADOLESCENT; AGED; BLOOD ANALYSIS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SAUDI ARABIA; YOUNG ADULT;

EID: 84966587849     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0490     Document Type: Article

References (30)

1. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003;334:5-23.
2. Johnson AM, Hyltoft Petersen P, Whicher JT, Carlstrom A, MacLennan S. Reference intervals for serum proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK. Clin Chem Lab Med 2004; 42:792-9.
3. IFCC and CLSI. C28-A3 document. Defining, establishing and verifying reference intervals in the clinical laboratory: approved guideline, 3rd ed., vol. 28 No. 30; 2008.
4. Solberg HE, Stamm D. International Federation of Clinical Chemistry (IFCC) IFCC recommendation. The Theory of Reference Values. Part 4 Control of analytical variation in the production, transfer and application of reference values. Ann Biol Clin (Paris) 1991;49:487-90.
5. Horn PS, Pesce AJ. Effect of ethnicity on reference intervals. Clin Chem 2002;48:1802-4.
6. El-Hazmi MA, Warsy AS. Evaluation of serum cholesterol and triglyceride levels in 1-6-year-old Saudi children. J Trop Pediatr 2001;47:181-5.
7. Ardawi MS, Maimani AA, Bahksh TA, Rouzi AA, Qari MH, Raddadi RM. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study. Bone 2010;47:804-14.
8. Scott TG. A pilot study of the reference values for the commoner haematological and biochemical parameters in Saudi nationals. J Clin Pathol 1982;35:69-73.
9. Tamimi W, Albanyan E, Altwaijri Y, Tamim H, Alhussein F. Age-and gender-specific reference intervals for fasting blood glucose and lipid levels in school children measured with abbott architect c8000 chemistry analyzer. Indian J Clin Biochem 2012;27:141-6.
10. El-Hazmi MA, Al-Faleh FZ, Al-Mofleh IA, Warsy AS, Al-Askah AK. Establishment of normal "reference" ranges for biochemical parameters for healthy Saudi Arabs. Trop Geogr Med 1982;34:323-32.
11. Ichihara K, Boyd JC, IFCC Committee on Reference Intervals and Decision Limits (C-RIDL). An appraisal of statistical procedures used in derivation of reference intervals. Clin Chem Lab Med 2010;48:1537-51.
12. Ichihara K. Statistical considerations for harmonization of the global multicenter study on reference values. Clin Chim Acta 2014;432:108-18.
13. Ozarda Y, Ichihara K, Barth JH, Klee G; Committee on Reference Intervals and Decision Limits (C-RIDL), International Federation for Clinical Chemistry and Laboratory Medicine. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. Clin Chem Lab Med 2013;51:1027-40.
14. Ichihara K, Ceriotti F, Tam TH, Sueyoshi S, Poon PM, Thong ML, et al. The Asian project for collaborative derivation of reference intervals: (1) strategy and major results of standardized analytes. Clin Chem Lab Med 2013;51:1429-42.
15. Ichihara K, Ceriotti F, Kazuo M, Huang YY, Shimizu Y, Suzuki H, et al. The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results. Clin Chem Lab Med 2013;51:1443-57.
16. Ichihara K, Itoh Y, Lam CW, Poon PM, Kim JH, Kyono H, et al. Sources of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals. Clin Chem 2008;54:356-65.
17. Ichihara K, Kawai T. Determination of reference intervals for 13 plasma proteins based on IFCC international reference preparation (CRM470) and NCCLS proposed guideline (C28-P,1992): trial to select reference individuals by results of screening tests and application of maximal likelihood method. J Clin Lab Anal 1996;10:110-17.
18. Ichihara K, Ozarda Y, Klee G, Straseski J, Baumann N, Ishikura K, et al. Utility of a panel of sera for the alignment of test results in the worldwide multicenter study on reference values. Clin Chem Lab Med 2013;51:1007-25.
19. Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med 2011;31: 19-23.
20. Allam AR, Taha IM, Al-Nozha OM, Sultan IE. Nutritional and health status of medical students at a university in Northwestern Saudi Arabia. Saudi Med J 2012;33:1296-03.
21. Lin J, Zhang M, Song F, Qin J, Wang R, Yao P, et al. Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population. Diabetes Metab Res Rev 2009; 25:219-23.
22. Sabanayagam C, Shankar A, Lim SC, Lee J, Tai ES, Wong TY. Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 2011;54:767-75.
23. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
24. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
25. Kogiso T, Moriyoshi Y, Shimizu S, Nagahara H, Shiratori K. High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population. J Gastroenterol 2009;44:313-21.
26. Rahman Al-Nuaim A. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years. Int J Cardiol 1997;62:227-35.
27. Al-Nozha M, Al-Khadra A, Arafah MR, Al-Maatouq MA, Khalil MZ, Khan NB, et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005;26:1918-25.
28. Afifi MM. Metabolic syndrome in Saudi Arabia. Saudi Med J 2006;27:1087; author reply 1088.
29. Alarouj M, Bennakhi A, Alnesef Y, Sharifi M, Elkum N. Diabetes and associated cardiovascular risk factors in the State of Kuwait: the first national survey. Int J Clin Pract 2013;67:89-96.
30. Alharbi NS, Almutari R, Jones S, Al-Daghri N, Khunti K, de Lusignan S. Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: systematic review and meta-analysis. Diabetes Res Clin Pract 2014;106:e30-33.